David L. Sobell

Mr. David L.
Sobell is a Vice President & Portfolio Manager at Amundi Asset Management US, Inc. He joined the firm in November 2000 and is a Member of the Growth team at Amundi.
Based in Boston, he focuses on biotechnology, medical device and healthcare stocks.
Prior to joining Amundi, he was a Vice President at Hambrecht & Quist Capital Management, where he assisted in the management of a closed-end investment fund.
Mr. David Sobell also worked for Rodman & Renshaw, Inc., as a sell-side equity analyst focusing on the pharmaceutical, drug delivery, and biotechnology industries.
Earlier in his career he was a research scientist at the Massachusetts Institute of Technology and at GENE-TRAK Systems, where he worked on developing diagnostic tests for infectious diseases.
Mr. Sobell holds a B.A.
in Molecular, Cellular and Developmental Biology from the University of Colorado.
He also holds a Certificate of Special Studies in Administration and Management from Harvard Extension School, and a Master’s in Management from the M.I.T.
Sloan School of Management.